# Adverse effects of biologics: a network meta-analysis and Cochrane overview

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adverse-effects-of-biologics-a-network-meta-analysis-and-cochrane-overview/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jasvinder A. Singh,George A. Wells,Robin Christensen,Elizabeth Tanjong Ghogomu,Lara Maxwell,John K MacDonald,Graziella Filippini,Nicole Skoetz,Damian Francis,Luciane Cruz Lopes,Gordon Guyatt,Jochen Schmitt,L. La Mantia,Tobias Weberschock,Juliana F. Roos,H. Siebert,Sarah Hershan,Chris Cameron,Michael P. Lunn,Peter Tugwell,Rachelle Buchbinder |
| Citations | 826 |
| DOI | 10.1002/14651858.cd008794.pub2 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7173749 |
| OpenAlex ID | https://openalex.org/W1701993624 |
| PMID | 21328309 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Peter Tugwell](https://scholariq.org/researchers/peter-tugwell/)
- [Gordon Guyatt](https://scholariq.org/researchers/gordon-guyatt/)
- [Jochen Schmitt](https://scholariq.org/researchers/jochen-schmitt/)

## Paper journal

- [Cochrane Database of Systematic Reviews](https://scholariq.org/journals/cochrane-database-of-systematic-reviews/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.